Suppr超能文献

慢性丙型肝炎临床隐匿性肝硬化非侵入性诊断的简单检测方法比较

Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C.

作者信息

Borroni G, Ceriani R, Cazzaniga M, Tommasini M, Roncalli M, Maltempo C, Felline C, Salerno F

机构信息

Dipartimento Dipendenze, ASL Provincia di Milano 1, Legnano (MI), Italy.

出版信息

Aliment Pharmacol Ther. 2006 Sep 1;24(5):797-804. doi: 10.1111/j.1365-2036.2006.03034.x.

Abstract

BACKGROUND

Biopsy is the gold standard for assessing cirrhosis in patients with chronic hepatitis C virus infection, but it is expensive and at risk of complications. Alternative non-invasive methods have been developed but their usefulness remains uncertain.

AIM

To compare the accuracy of five non-invasive scores in detecting cirrhosis.

METHODS

We reviewed the charts and liver biopsies of 228 consecutive, treatment-naïve, hepatitis C virus-positive patients, 13.2% of whom with histological diagnosis of cirrhosis. The five alternative scores were age-platelet index, cirrhosis discriminant score, aspartate transaminases to platelet ratio index, Pohl's index, and aspartate transaminases/alanine transaminases ratio.

RESULTS

The specificities of the scores were good (87-100%), but not so their sensitivities (17-67%). Accordingly positive likelihood ratios were generally good but negative likelihood ratios were suboptimal. Combinations of the scores independently related to cirrhosis only slightly change this diagnostic accuracy. Using double cut-offs to exclude/diagnoses cirrhosis, cirrhosis discriminant score classified 21% of patients without misdiagnoses and aspartate transaminases to platelet ratio index classified 85% of case with 9% of misdiagnoses.

CONCLUSIONS

The five scores showed variable sensitivities and specificities in detecting liver cirrhosis, both individually and in combination. The use of double cut-off points may make the cirrhosis discriminant score and aspartate transaminases to platelet ratio index useful to reduce the number of patients submitted to liver biopsy.

摘要

背景

活检是评估慢性丙型肝炎病毒感染患者肝硬化的金标准,但它费用高昂且有并发症风险。已开发出替代的非侵入性方法,但其有效性仍不确定。

目的

比较五种非侵入性评分在检测肝硬化方面的准确性。

方法

我们回顾了228例连续的、未经治疗的丙型肝炎病毒阳性患者的病历和肝活检结果,其中13.2%经组织学诊断为肝硬化。这五种替代评分分别是年龄-血小板指数、肝硬化判别评分、天冬氨酸转氨酶与血小板比值指数、波尔指数和天冬氨酸转氨酶/丙氨酸转氨酶比值。

结果

这些评分的特异性良好(87%-100%),但敏感性并非如此(17%-67%)。相应地,阳性似然比总体良好,但阴性似然比并不理想。与肝硬化独立相关的评分组合仅略微改变了这种诊断准确性。使用双临界值来排除/诊断肝硬化,肝硬化判别评分正确分类了21%的患者且无误诊,天冬氨酸转氨酶与血小板比值指数正确分类了85%的病例,误诊率为9%。

结论

这五种评分在检测肝硬化方面,无论是单独使用还是联合使用,其敏感性和特异性都各不相同。使用双临界值可能会使肝硬化判别评分和天冬氨酸转氨酶与血小板比值指数有助于减少接受肝活检的患者数量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验